Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 6/2021

01-06-2021 | Ampicillin | Brief Report

Performance of the VITEK®2 advanced expert system™ for the validation of antimicrobial susceptibility testing results

Authors: L Pages monteiro, N. Von Allmen, I. Friesen, K. Huth, G. Zambardi

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 6/2021

Login to get access

Abstract

Time to reporting antimicrobial susceptibility testing (AST) results to physicians plays an essential role in antibiotic stewardship programs. Expert software has been developed for facilitating the microbiologists’ AST review process. The reliability of the VITEK®2 Advanced Expert™ software to effectively alert the microbiologist in detection of atypical and inconsistent AST results was assessed at the Labor Berlin—Charité Vivantes services. The results demonstrated a confidence rate of 99.3% in reporting fully consistent AST results to physicians.
Literature
1.
Barenfanger J, Drake C, Kacich G (1999) Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 37(5):1415–1418CrossRef
2.
Buroni S, Pollini S, Rossolini GM, Perrin E (2019) Editorial: evolution of genetic mechanisms of antibiotic resistance. Front Genet 10:983CrossRef
3.
Leclercq R, Nicolas-Chanoine MH, Nordmann P, Philippon A, Marchais P, Buu-Ho A, et al. 2001 Multicenter evaluation of an automated system using selected bacteria that harbor challenging and clinically relevant mechanisms of resistance to antibiotics. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology ;20(9):626–35
4.
Leekha S, Terrell CL, Edson RS (2011) General principles of antimicrobial therapy. Mayo Clin Proc 86(2):156–167CrossRef
5.
Livermore DM, Struelens M, Amorim J, Baquero F, Bille J, Canton R et al (2002) Multicentre evaluation of the VITEK 2 advanced expert system for interpretive reading of antimicrobial resistance tests. J Antimicrob Chemother 49(2):289–300CrossRef
6.
Malik B, Bhattacharyya S (2019) Antibiotic drug-resistance as a complex system driven by socio-economic growth and antibiotic misuse. Sci Rep 9(1):9788CrossRef
7.
Rhoads DD, Sintchenko V, Rauch CA, Pantanowitz L (2014) Clinical microbiology informatics. Clin Microbiol Rev 27(4):1025–1047CrossRef
8.
Winstanley T, Courvalin P (2011) Expert systems in clinical microbiology. Clin Microbiol Rev 24(3):515–556CrossRef
Metadata
Title
Performance of the VITEK®2 advanced expert system™ for the validation of antimicrobial susceptibility testing results
Authors
L Pages monteiro
N. Von Allmen
I. Friesen
K. Huth
G. Zambardi
Publication date
01-06-2021
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 6/2021
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-021-04162-0

Other articles of this Issue 6/2021

European Journal of Clinical Microbiology & Infectious Diseases 6/2021 Go to the issue

Original Article

Characteristics and outcome according to underlying disease in non-AIDS patients with acute respiratory failure due to Pneumocystis pneumonia

Original Article

Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis

Original Article

Comparison of nine different commercially available molecular assays for detection of SARS-CoV-2 RNA

Brief Report

Antibody response in patients admitted to the hospital with suspected SARS-CoV-2 infection: results from a multicenter study across Spain

Original Article

C-reactive protein and the neonatal early-onset sepsis calculator for the diagnosis of neonatal sepsis

Review

Fosfomycin in continuous or prolonged infusion for systemic bacterial infections: a systematic review of its dosing regimen proposal from in vitro, in vivo and clinical studies
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits